Cargando…
A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV)
BACKGROUND: The Capripoxvirus, Lumpy skin disease virus (LSDV) has a restricted host-range and is being investigated as a novel HIV-1 vaccine vector. LSDV does not complete its replication cycle in non-ruminant hosts. METHODS: The safety of LSDV was tested at doses of 10(4 )and 10(6 )plaque forming...
Autores principales: | Shen, Yen-Ju, Shephard, Enid, Douglass, Nicola, Johnston, Nicolette, Adams, Craig, Williamson, Carolyn, Williamson, Anna-Lise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117847/ https://www.ncbi.nlm.nih.gov/pubmed/21624130 http://dx.doi.org/10.1186/1743-422X-8-265 |
Ejemplares similares
-
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector
por: van Diepen, Michiel, et al.
Publicado: (2021) -
Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity
por: Douglass, Nicola, et al.
Publicado: (2020) -
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021) -
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
por: de Moor, Warren R. J., et al.
Publicado: (2023) -
Potential mechanical transmission of Lumpy skin disease virus (LSDV) by the stable fly (Stomoxys calcitrans) through regurgitation and defecation
por: Paslaru, Anca I., et al.
Publicado: (2020)